PAVmed Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PAVmed Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PAVmed Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- PAVmed Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-03-31 was $260.00K, a 15.31% decline year-over-year.
- PAVmed Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-12-31 was -$1.00K, a 100.06% decline year-over-year.
- PAVmed Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $2.02M, a 79.80% decline from fiscal 2023.
- PAVmed Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $10.00M.
- PAVmed Inc. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $8.09M.
- PAVmed Inc. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $27.34K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $259.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.17M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | $260.00K 10-Q · filed 2025-05-15 | $1.97M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $2.02M 10-K · filed 2025-03-24 |
| 2024-09-30 | $908.00K 10-Q · filed 2025-11-12 | $3.61M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $806.00K 10-Q · filed 2025-08-14 | $6.69M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $307.00K 10-Q · filed 2025-05-15 | $8.28M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $10.00M 10-K · filed 2025-03-24 |
| 2023-09-30 | $3.99M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $2.40M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $2.03M 10-Q · filed 2024-05-13 | |
| 2022-09-30 | $10.11M 10-Q · filed 2023-11-13 | |
| 2019-12-31 | $8.09M 10-K · filed 2020-04-14 | |
| 2017-12-31 | $27.34K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |